scholarly journals Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation

2020 ◽  
Vol 61 (2) ◽  
pp. 231
Author(s):  
Derrick J. Sanderson ◽  
Matthew Gevelinger ◽  
Elaine Jaworski ◽  
Paula J. Doyle
Keyword(s):  
Overactive Bladder ◽  
Sleep Disturbance ◽  
Sacral Neuromodulation

Sacral Neuromodulation with the InterStim System for Overactive Bladder: 3-Year Results from the French Prospective, Multicenter, Observational SOUNDS Study

2021 ◽  
Author(s):  
Emmanuel Chartier-Kastler ◽  
Loïc Le Normand ◽  
Alain Ruffion ◽  
Christian Saussine ◽  
Raïssa Braguet ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Sacral Neuromodulation

Update on sacral neuromodulation and overactive bladder in pediatrics: a systematic review.

2021 ◽  
Author(s):  
Isabel Casal Beloy ◽  
María García-Novoa ◽  
Miriam García González ◽  
Iván Somoza Argibay
Keyword(s):  
Systematic Review ◽  
Overactive Bladder ◽  
Sacral Neuromodulation

scholarly journals Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder

2018 ◽  
Vol 17 (2) ◽  
pp. e1352-e1353
Author(s):  
P.E. Van Kerrebroeck ◽  
S. De Wachter ◽  
A. Ruffion ◽  
F. Van Der Aa ◽  
M.-A. Perrouin-Verbe ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Prospective Study ◽  
Sacral Neuromodulation ◽  
A Prospective Study

Introduction to sacral neuromodulation therapy for urinary bladder dysfunction using an InterStim system

2020 ◽  
Vol 29 (9) ◽  
pp. S23-S26 ◽  
Author(s):  
Frances Harries
Keyword(s):  
Breast Cancer ◽  
Urinary Bladder ◽  
Overactive Bladder ◽  
Sacral Neuromodulation ◽  
Bladder Dysfunction ◽  
Queen Elizabeth Hospital ◽  
Urinary Bladder Dysfunction ◽  
Satisfaction With Treatment ◽  
Bladder Symptoms ◽  
The Individual

Sacral neuromodulation is an internationally endorsed therapy recognised by the National Institute for Health and Care Excellence for patients who have refractory overactive bladder symptoms and/or idiopathic non-obstructive urinary retention when conservative treatments have failed or when patients have been unable to tolerate them. The Medtronic InterStim System used at the Queen Elizabeth Hospital Birmingham received CE mark approval in 1995 for bladder indications. To date, over 300 000 patients worldwide have been treated, with 61–90% reporting satisfaction with treatment ( Sutherland et al, 2007 ; Leong et al, 2011 ). It is a safe and effective intervention that can positively impact upon the management of both of these conditions, in particular overactive bladder. This highly prevalent condition is distressing to the individual and has an economic burden to society comparable in magnitude with that of breast cancer and osteoporosis ( Hu and Wagner, 2005 ).

What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder

2019 ◽  
Vol 299 (5) ◽  
pp. 1243-1252 ◽  
Author(s):  
Matthias Oelke ◽  
Mustapha Addali ◽  
Christl Reisenauer
Keyword(s):  
Overactive Bladder ◽  
Sacral Neuromodulation
Sign in / Sign up

Export Citation Format

Share Document